Avai Bio (AVAI) EBIT Margin (2019 - 2020)
Avai Bio's EBIT Margin history spans 2 years, with the latest figure at 269.52% for Q4 2020.
- For Q4 2020, EBIT Margin changed N/A year-over-year to 269.52%; the TTM value through Dec 2022 reached 414.23%, changed N/A, while the annual FY2025 figure was 292.34%, 2664845.0% down from the prior year.
- EBIT Margin for Q4 2020 was 269.52% at Avai Bio, up from 20.55% in the prior quarter.
- Across five years, EBIT Margin topped out at 269.52% in Q4 2020 and bottomed at 244.93% in Q2 2019.